27769207|t|Neonatal outcomes in pregnancies resulting from oocyte donation: a cohort study in Sweden
27769207|a|Pregnancies resulting through oocyte donation have been associated with increased risk for adverse outcomes for the mother, such as gestational hypertensive disorders. However, little is known about possible neonatal complications of such pregnancies. The purpose of this study was to evaluate the neonatal health outcomes among singleton pregnancies in a population of relatively young and healthy oocyte recipients in Sweden, taking into account the medical indication leading to treatment. This cohort study involved 76 women conceiving with donated oocytes, 149 age - matched nulliparous women conceiving spontaneously and 63 women conceiving after non-donor IVF. Participants were recruited during 2005-2008 and followed up until delivery. Data on neonatal outcomes were retrieved from the National Birth Medical Register and the medical records of oocyte recipients from seven Swedish University Hospitals with IVF clinics. Logistic regression analyses were performed to examine the association of mode of conception and neonatal outcomes, adjusted for maternal age and BMI, gestational age and delivery by cesarean section. Infants conceived through oocyte donation had higher odds for premature delivery [OR 2.36, 95 % CI (1.02-5.45)], for being small for gestational age [OR 4.23, 95 % CI (1.03-17.42)] and having Apgar score below 7 at 5 min [OR 10.57, 95 % CI (1.21-92.20)] compared to spontaneously conceived infants. Similar trends were observed when comparing infants conceived through oocyte donation to those conceived by traditional IVF. Furthermore, donor oocyte infants had a lower mean birthweight and length compared to autologous oocyte neonates (p = 0.013); however no differences were noted among infants born at term. Neonatal outcomes were more favorable among women with diminished ovarian reserve compared to those with other indication s for oocyte donation. Infants conceived after oocyte donation in Sweden have higher odds of being born prematurely and having lower mean birthweight in comparison to non-donor infants. It seems that these unfavorable neonatal outcomes are present despite the age, weight and health restrictions applied to recipients before oocyte donation treatment in Sweden.
27769207	0	8	Neonatal	T079	C2939425
27769207	9	17	outcomes	T033	C0032972
27769207	21	32	pregnancies	T040	C0032961
27769207	33	42	resulting	T169	C1274040
27769207	48	63	oocyte donation	T061	C0242813
27769207	67	79	cohort study	T081	C0009247
27769207	83	89	Sweden	T083	C0038995
27769207	90	101	Pregnancies	T040	C0032961
27769207	102	111	resulting	T169	C1274040
27769207	120	135	oocyte donation	T061	C0242813
27769207	146	161	associated with	T080	C0332281
27769207	162	176	increased risk	T033	C0332167
27769207	181	188	adverse	T046	C0879626
27769207	189	197	outcomes	T033	C0032972
27769207	206	212	mother	T099	C0026591
27769207	222	256	gestational hypertensive disorders	T047	C0852036
27769207	289	297	possible	T033	C0332149
27769207	298	306	neonatal	T079	C2939425
27769207	307	320	complications	T046	C0009566
27769207	329	340	pregnancies	T040	C0032961
27769207	346	353	purpose	T169	C1285529
27769207	362	367	study	T062	C2603343
27769207	375	383	evaluate	T058	C0220825
27769207	388	396	neonatal	T079	C2939425
27769207	397	403	health	T078	C0018684
27769207	404	412	outcomes	T033	C0032972
27769207	419	428	singleton	T099	C1313913
27769207	429	440	pregnancies	T040	C0032961
27769207	446	456	population	T098	C1257890
27769207	471	476	young	T079	C0332239
27769207	481	488	healthy	T080	C3898900
27769207	489	495	oocyte	T025	C0029045
27769207	496	506	recipients	T098	C1709854
27769207	510	516	Sweden	T083	C0038995
27769207	530	537	account	T033	C0518609
27769207	542	549	medical	T169	C0205476
27769207	550	560	indication	T078	C3146298
27769207	572	581	treatment	T061	C0087111
27769207	588	600	cohort study	T081	C0009247
27769207	613	618	women	T098	C0043210
27769207	619	629	conceiving	T169	C0232908
27769207	635	650	donated oocytes	T025	C2599203
27769207	656	659	age	T032	C0001779
27769207	662	669	matched	T080	C1708943
27769207	670	687	nulliparous women	T033	C0425979
27769207	688	698	conceiving	T169	C0232908
27769207	699	712	spontaneously	T169	C0205359
27769207	720	725	women	T098	C0043210
27769207	726	736	conceiving	T169	C0232908
27769207	743	756	non-donor IVF	T061	C0015915
27769207	758	770	Participants	T098	C0679646
27769207	776	785	recruited	T052	C2949735
27769207	807	818	followed up	T058	C1522577
27769207	825	833	delivery	T040	C0005615
27769207	835	839	Data	T078	C1511726
27769207	843	851	neonatal	T079	C2939425
27769207	852	860	outcomes	T033	C0032972
27769207	866	875	retrieved	T169	C1301820
27769207	885	893	National	T092	C0015737
27769207	894	899	Birth	T040	C0005615
27769207	900	907	Medical	T169	C0205476
27769207	908	916	Register	T170	C0600375
27769207	925	940	medical records	T170	C0025102
27769207	944	950	oocyte	T025	C0029045
27769207	951	961	recipients	T098	C1709854
27769207	973	1001	Swedish University Hospitals	T073,T093	C0019994
27769207	1007	1010	IVF	T061	C0015915
27769207	1011	1018	clinics	T073,T093	C0442592
27769207	1020	1048	Logistic regression analyses	UnknownType	C0681925
27769207	1054	1063	performed	T169	C0884358
27769207	1067	1074	examine	T033	C0332128
27769207	1079	1090	association	T080	C0439849
27769207	1094	1098	mode	T169	C1513371
27769207	1102	1112	conception	T040	C0009637
27769207	1117	1125	neonatal	T079	C2939425
27769207	1126	1134	outcomes	T033	C0032972
27769207	1136	1144	adjusted	T169	C0456081
27769207	1149	1161	maternal age	T079	C0024915
27769207	1166	1169	BMI	T201	C1305855
27769207	1171	1186	gestational age	T032	C0017504
27769207	1191	1199	delivery	T040	C0005615
27769207	1203	1219	cesarean section	T061	C0007876
27769207	1221	1228	Infants	T100	C0021270
27769207	1229	1238	conceived	T169	C0232908
27769207	1247	1262	oocyte donation	T061	C0242813
27769207	1267	1273	higher	T080	C0205250
27769207	1274	1278	odds	T081	C0033204
27769207	1283	1301	premature delivery	T033	C0151526
27769207	1344	1349	small	T081	C0700321
27769207	1354	1369	gestational age	T032	C0017504
27769207	1413	1424	Apgar score	T032	C0003533
27769207	1438	1441	min	T081	C1282918
27769207	1475	1483	compared	T052	C1707455
27769207	1487	1500	spontaneously	T169	C0205359
27769207	1501	1510	conceived	T169	C0232908
27769207	1511	1518	infants	T100	C0021270
27769207	1540	1548	observed	T169	C1441672
27769207	1554	1563	comparing	T052	C1707455
27769207	1564	1571	infants	T100	C0021270
27769207	1572	1581	conceived	T169	C0232908
27769207	1590	1605	oocyte donation	T061	C0242813
27769207	1615	1624	conceived	T169	C0232908
27769207	1628	1639	traditional	T061	C3650840
27769207	1640	1643	IVF	T061	C0015915
27769207	1658	1670	donor oocyte	T025	C2599203
27769207	1671	1678	infants	T100	C0021270
27769207	1685	1707	lower mean birthweight	T033	C0024032
27769207	1712	1718	length	T033	C0419415
27769207	1719	1727	compared	T052	C1707455
27769207	1731	1741	autologous	T080	C0439859
27769207	1742	1748	oocyte	T025	C0029045
27769207	1749	1757	neonates	T100	C0021289
27769207	1779	1793	no differences	T033	C3842396
27769207	1799	1804	noted	T169	C1441672
27769207	1811	1818	infants	T100	C0021270
27769207	1819	1831	born at term	T040	C0233324
27769207	1833	1841	Neonatal	T079	C2939425
27769207	1842	1850	outcomes	T033	C0032972
27769207	1877	1882	women	T098	C0043210
27769207	1888	1914	diminished ovarian reserve	T047	C3839507
27769207	1915	1923	compared	T052	C1707455
27769207	1944	1954	indication	T078	C3146298
27769207	1961	1976	oocyte donation	T061	C0242813
27769207	1978	1985	Infants	T100	C0021270
27769207	1986	1995	conceived	T169	C0232908
27769207	2002	2017	oocyte donation	T061	C0242813
27769207	2021	2027	Sweden	T083	C0038995
27769207	2033	2039	higher	T080	C0205250
27769207	2040	2044	odds	T081	C0033204
27769207	2054	2070	born prematurely	T033	C0233315
27769207	2082	2104	lower mean birthweight	T033	C0024032
27769207	2108	2118	comparison	T052	C1707455
27769207	2122	2139	non-donor infants	T100	C0021270
27769207	2161	2172	unfavorable	T046	C0879626
27769207	2173	2181	neonatal	T079	C2939425
27769207	2182	2190	outcomes	T033	C0032972
27769207	2195	2202	present	T033	C0150312
27769207	2215	2218	age	T032	C0001779
27769207	2220	2226	weight	T032	C0005910
27769207	2231	2237	health	T078	C0018684
27769207	2238	2250	restrictions	T169	C0443288
27769207	2262	2272	recipients	T098	C1709854
27769207	2280	2295	oocyte donation	T061	C0242813
27769207	2296	2305	treatment	T061	C0087111
27769207	2309	2315	Sweden	T083	C0038995